Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 2
2014 3
2015 3
2016 3
2017 1
2019 1
2020 1
2021 1
2022 1
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

14 results
Results by year
Filters applied: . Clear all
Page 1
Current Insights into Long Non-Coding RNAs in Renal Cell Carcinoma.
Seles M, Hutterer GC, Kiesslich T, Pummer K, Berindan-Neagoe I, Perakis S, Schwarzenbacher D, Stotz M, Gerger A, Pichler M. Seles M, et al. Among authors: schwarzenbacher d. Int J Mol Sci. 2016 Apr 15;17(4):573. doi: 10.3390/ijms17040573. Int J Mol Sci. 2016. PMID: 27092491 Free PMC article. Review.
Current Status of Long Non-Coding RNAs in Human Breast Cancer.
Cerk S, Schwarzenbacher D, Adiprasito JB, Stotz M, Hutterer GC, Gerger A, Ling H, Calin GA, Pichler M. Cerk S, et al. Among authors: schwarzenbacher d. Int J Mol Sci. 2016 Sep 6;17(9):1485. doi: 10.3390/ijms17091485. Int J Mol Sci. 2016. PMID: 27608009 Free PMC article. Review.
The role of microRNAs in breast cancer stem cells.
Schwarzenbacher D, Balic M, Pichler M. Schwarzenbacher D, et al. Int J Mol Sci. 2013 Jul 15;14(7):14712-23. doi: 10.3390/ijms140714712. Int J Mol Sci. 2013. PMID: 23860207 Free PMC article. Review.
ALYREF, a novel factor involved in breast carcinogenesis, acts through transcriptional and post-transcriptional mechanisms selectively regulating the short NEAT1 isoform.
Klec C, Knutsen E, Schwarzenbacher D, Jonas K, Pasculli B, Heitzer E, Rinner B, Krajina K, Prinz F, Gottschalk B, Ulz P, Deutsch A, Prokesch A, Jahn SW, Lellahi SM, Perander M, Barbano R, Graier WF, Parrella P, Calin GA, Pichler M. Klec C, et al. Among authors: schwarzenbacher d. Cell Mol Life Sci. 2022 Jul 1;79(7):391. doi: 10.1007/s00018-022-04402-2. Cell Mol Life Sci. 2022. PMID: 35776213 Free PMC article.
Pharmacokinetics and Pharmacodynamics of Three Different Formulations of Insulin Aspart: A Randomized, Double-Blind, Crossover Study in Men With Type 1 Diabetes.
Svehlikova E, Mursic I, Augustin T, Magnes C, Gerring D, Jezek J, Schwarzenbacher D, Ratzer M, Wolf M, Howell S, Zakrzewski L, Urschitz M, Tschapeller B, Gatschelhofer C, Feichtner F, Lawrence F, Pieber TR. Svehlikova E, et al. Among authors: schwarzenbacher d. Diabetes Care. 2021 Feb;44(2):448-455. doi: 10.2337/dc20-1017. Epub 2020 Dec 16. Diabetes Care. 2021. PMID: 33328285 Free PMC article. Clinical Trial.
Low spinophilin expression enhances aggressive biological behavior of breast cancer.
Schwarzenbacher D, Stiegelbauer V, Deutsch A, Ress AL, Aigelsreiter A, Schauer S, Wagner K, Langsenlehner T, Resel M, Gerger A, Ling H, Ivan C, Calin GA, Hoefler G, Rinner B, Pichler M. Schwarzenbacher D, et al. Oncotarget. 2015 May 10;6(13):11191-202. doi: 10.18632/oncotarget.3586. Oncotarget. 2015. PMID: 25857299 Free PMC article.
KCNJ3 is a new independent prognostic marker for estrogen receptor positive breast cancer patients.
Kammerer S, Sokolowski A, Hackl H, Platzer D, Jahn SW, El-Heliebi A, Schwarzenbacher D, Stiegelbauer V, Pichler M, Rezania S, Fiegl H, Peintinger F, Regitnig P, Hoefler G, Schreibmayer W, Bauernhofer T. Kammerer S, et al. Among authors: schwarzenbacher d. Oncotarget. 2016 Dec 20;7(51):84705-84717. doi: 10.18632/oncotarget.13224. Oncotarget. 2016. PMID: 27835900 Free PMC article.
14 results